Trial
NCT00163241
Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Osteoarthritis
Intervention
celecoxib
Why stopped
Please see detailed description for termination reason.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-03